Breaking

GLP-1 Drugs Reshaping Food and Beverage Freight Demand

Appetite-suppressing medications are beginning to measurably impact food and beverage shipping volumes. FreightWaves estimates a 2% reduction in that sector, representing roughly 2 million truckloads annually out of 100 million total moves.

Walmart data linking pharmacy records with grocery purchases reveals households with male GLP-1 users show 10% fewer calorie purchases, while female-user households show 6% to 8% reductions. The disparity reflects women continuing to shop for children and other household members.

Snack foods and beverages face the steepest declines. Industry observers point to softer-than-expected summer volumes in beer and soda—traditionally strong seasons—as an early indicator of structural demand shifts.

Beyond appetite suppression, the medications reduce cravings for all consumptive behaviors. Ryan Schreiber, who lost 125 pounds over roughly two and a half to three years on GLP-1 therapy, noted the effect extends beyond food. Don Everhart at Transflo reported zero alcohol consumption since starting GLP-1 therapy, reflecting a broader pattern of reduced alcohol consumption. Combined with generational drinking pattern changes among younger consumers, beverage-focused freight lanes face compounding pressure.